X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.
X-Therma is a biotechnology firm that is developing a convergent biopreservation platform to advance regenerative medicine. Using convergent biomimetic nanotechnology, the company is addressing unmet legacy needs in biological product storage. This solution can improve critical biomanufacturing processes, safer transport, and long-term biobanking for advanced cell therapies, IVF, organ transplants, and other rapidly growing regenerative medicine areas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 22, 2021 | Series A | $13M | 2 | LOREA AG | — | Detail |
Sep 4, 2018 | Grant | $1.24M | 1 | National Science Foundation | — | Detail |
Jun 21, 2016 | Grant | $224.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
LOREA AG | Yes | Series A |
National Science Foundation | Yes | Grant |
Zen11 Holdings | — | Series A |